Waqas N. Baba et al. (2021) showed that bioactive peptides from camel whey hydrolysate can assist in the treatment of hypercholesterolemia by inhibiting pancreatic lipase and cholesterol esterase. Here, PNLIP is linked to familial hypercholesterolemia.